Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma.

Autor: Shih DJH; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA., Nayyar N; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Program in Molecular Medicine, UMass Medical School, Worcester, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Bihun I; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Dagogo-Jack I; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Gill CM; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.; Icahn School of Medicine, Mount Sinai, New York, NY, USA., Aquilanti E; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Bertalan M; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Kaplan A; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., D'Andrea MR; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Chukwueke U; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ippen FM; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Alvarez-Breckenridge C; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA., Camarda ND; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA., Lastrapes M; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McCabe D; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kuter B; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Kaufman B; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA., Strickland MR; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Martinez-Gutierrez JC; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA., Nagabhushan D; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., De Sauvage M; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., White MD; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Castro BA; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Hoang K; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Kaneb A; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Batchelor ED; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Paek SH; Department of Neurosurgery, Seoul National University College of Medicine, Seoul, South Korea.; Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea., Park SH; Department of Neurosurgery, Seoul National University College of Medicine, Seoul, South Korea.; Department of Pathology, Seoul National University College of Medicine, Seoul, South Korea., Martinez-Lage M; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Berghoff AS; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Center Vienna, Vienna, Austria., Merrill P; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Gerstner ER; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Batchelor TT; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA., Frosch MP; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Frazier RP; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Borger DR; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Iafrate AJ; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA., Johnson BE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA., Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA.; Ludwig Center at Harvard Medical School, Boston, MA, USA., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Comprehensive Cancer Center Vienna, Vienna, Austria., Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA., Carter SL; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. carter.scott@jimmy.harvard.edu.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA. carter.scott@jimmy.harvard.edu.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA. carter.scott@jimmy.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. carter.scott@jimmy.harvard.edu.; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. carter.scott@jimmy.harvard.edu., Brastianos PK; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA. pbrastianos@mgh.harvard.edu.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. pbrastianos@mgh.harvard.edu.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. pbrastianos@mgh.harvard.edu.

Publikováno v: Nature genetics [Nat Genet] 2020 Apr; Vol. 52 (4), pp. 371-377. Date of Electronic Publication: 2020 Mar 23.

Interaction of topical and oral timolol in glaucoma.

Autor: Batchelor ED, O'Day DM, Shand DG, Wood AJ

Publikováno v: Ophthalmology [Ophthalmology] 1979 Jan; Vol. 86 (1), pp. 60-5.